Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Argosy Capital is a diversified private investment firm focused on the lower middle market, with strategies spanning private equity, real estate, credit, secondaries, and healthcare investing. The firm is headquartered in Wayne, Pennsylvania and describes itself as an SEC-registered investment adviser with approximately $3.8 billion in assets under management. Within healthcare, it operates Argosy Healthcare Partners, a dedicated investment strategy targeting founder-owned healthcare companies across sectors such as pharmaceutical services, life sciences services and tools, medical device services, staffing, and payor services. Argosy Capital is therefore not itself a biotech, pharma, or healthcare operating company; rather, it is an investor and owner of healthcare-related portfolio companies. Its business model centers on partnering with management teams to build and grow market-leading platforms rather than developing therapeutic products internally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Argosy Capital.